期刊文献+

囊性颅咽管瘤立体定向内放疗的长期疗效分析 被引量:5

Long-term efficacy analysis of stereotactic brachytherapy for cystic craniopharyngiomas
原文传递
导出
摘要 目的探讨颅咽管瘤内放疗的长期治疗结果。方法对743例立体定向32 P内放疗的囊性颅咽管瘤患者进行长期疗效回顾性分析,术后门诊复查及电话随访10~20年(平均12.2年)。结果 743例颅咽管瘤治疗情况。CT/MR影像复查肿瘤体积变化:肿瘤消失416例(56.0%),明显缩小(>50%)221例(29.7%),无变化65例(8.7%),肿瘤复发41例(5.5%);临床症状:神经功能改善620例(83.4%),无变化73例(9.8%),恶化42例(5.7%),死亡9例(1.2%)。结论临床所见颅咽管瘤多数呈囊实性或囊性,可经此疗法治愈。立体定向内放疗不仅创伤较小,对囊性颅咽管瘤长期疗效也令人满意。 Objective To investigate the long-term results in clinical treatment of cystic craniopharyngioma with stereotactic brachytherapy.Methods Clinical data of 743 patients with cystic craniopharyngioma were analyzed retrospectively.All tumors were treated with stereotactic injection of isotope 32P.Results Followed-up 743 patients 10 to 20 years(average 12.2 years) by outpatient service and telephone inquire,tumors disappear in 416 cases(56.0%),subtotal removal in 221 cases(29.7%),stable in 65 cases(8.7%),recurrence in 41 cases(5.5%).Clinical symptoms improved in 620 cases(83.4%),stable in 73 cases(9.8%),worsened in 42(5.7%) and dead in 9 cases(1.2%).Conclusion Total tumor removal could be achieved in most craniopharyngioma with stereotactic injection of 32P.Since most craniopharyngiomas are cystic,which is conviniant for this therapy.Not only brachytherapy has minimal invasion to the patients,but also has good results for cystic craniopharyngioma during long time.
出处 《立体定向和功能性神经外科杂志》 2012年第2期97-99,共3页 Chinese Journal of Stereotactic and Functional Neurosurgery
基金 国家863课题项目(编号:2004AA421010)
关键词 颅咽管瘤 立体定向 近距离放射治疗 预后 Craniopharyngioma Stereotactic operation Brachytherapy Prognosis
  • 相关文献

参考文献1

共引文献4

同被引文献78

  • 1闫洪生,任洪军,闫建齐,邢建飞.立体定向^(32)P间质内放疗治疗脑深部及功能区囊性胶质瘤[J].河北医药,2007,29(1):25-26. 被引量:2
  • 2BARRIGER R B, CHANG A, LOS S, et al. Phosphorus - 32 therapy for cystic craniopharyngiomas [ J ]. Radiother On- col,2011, 98(2) :207 -212. 被引量:1
  • 3Liubinas SV, Munshey AS, Kaye AH. Management of recurrent craniopharyngioma[J]. J Clin Neurosci, 2011, 18 (4) :451-457. 被引量:1
  • 4Holsken A, Gebhardt M, Buchfelder M, et al. EGFR signaling regu- lates tumor cell migration in craniopharyngiomas[J]. Clin Cancer Res, 2011, 17(13):4367-4377. 被引量:1
  • 5XuJ, You C, Zhou L, et al. The cell-cycle kinetics of cralfiopharyn- gioma and its clinical significance[J]. J Neurooncol, 2010, 98(1): 71-76. 被引量:1
  • 6Li Q, You C, Zhou L, et al. All-trans retinoic acid inhibits cranio- pharyngioma cell growth: study on an explant cell model[J]. J Neu- rooncol, 2013, 112 (3):355-364. 被引量:1
  • 7Liu W, Fallg Y, Cai B, et al. Intracystic bleomycin for cystic cranio- pharyngiomas in children (abridged republication of cochrane sys- tematic review)[J]. Neurosurgery, 2012, 71 (5):909-915. 被引量:1
  • 8Caceres A. Intracavitary therapeutic options in the management of cystic craniopharyngioma[J]. Childs Nerv Syst 2005, 21(8-9): 705-718. 被引量:1
  • 9Kickingereder P, Maarouf M, E1 Majdoub F, et al. Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cysticcraniopharyngiomas in 53 patients[J]. J Neu- rooncol, 2012, 109(2):365-374. 被引量:1
  • 10Cavalheiro S, Di Rocco C, Valenzuela S, et al. Craniopharyngio- mas: intratumoral chemotherapy with interferon-alpha: a multi- center preliminary study with 60 cases[J]. Neurosurg Focus, 2010, 28(4):E12. 被引量:1

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部